Management Team
Our Management Team provides a wealth of knowledge and experience:
Liz Littlewood
Operations Director
Liz joined the team at 272BIO Limited as Operations Director in 2019. Liz has 26 years leadership experience in the Pharma/Biotech Industry. In 1996 Liz joined the Pfizer Animal Health Group in Sandwich as a team leader in in vitro pharmacology, working across…
Charles Owen
Founder
272BIO was founded by Charlie Owen in 2019 with the aim of delivering innovative therapeutic solutions using biotherapeutics to tackle unmet medical need across animal health. Charlie completed a PhD at Glasgow University investigating transcriptional…
Karine Clauwaert
Business Development
Karine Clauwaert joined the 272bio team in 2021 to drive business development. Karine qualified as a Pharmacist in 1992 and went on to gain a PhD in pharmaceutical sciences at Ghent University in the laboratory of toxicology in 1998. Between 1997 and 2003…
An Cerdobbel
CMC Subject Matter Expert
An Cerdobbel joined 272Bio in 2021 as a CMC Subject Matter Expert. An received a PhD in Bioscience Engineering from Ghent University (2010) for work performed in the field of applied biocatalysis. She then moved to Ablynx, where she was quickly promoted from Associate Scientist…
Dr Christine Labeur, PhD
VHH CMC Subject Matter Expert
Dr Christine Labeur, PhD Joined 272BIO in 2019 as our VHH CMC Subject Matter Expert. Since the start of her scientific career about 35 years ago Christine has been fascinated by the complexity and biochemistry of protein research which has resulted in achieving a broad global expertise of pharmaceutical…
Emma Campbell
Head of Translational Science
Emma is Translational Sciences Lead, bridging the gap between scientific and clinical fields. Emma also provides oversight of the Companion Animal Portfolio. Emma has over 20 years’ experience in drug discovery and pre-clinical development, successfully transitioning…
Inês Pimenta de Castro
Head of Portfolio Management
Inês Pimenta de Castro, PharmD, Ph.D., joned 272BIO as our Head of Portfolio Management in March 2022. Ines’ responsibilities include strategic scientific leadership, management of antibody discovery projects, external collaborations, partnerships management and operational activities. Before joining 272BIO…
Francois Bertelli
Head of Antibody Discovery
Francois Bertelli is Head of Antibody Research at 272Bio, leading the discovery of new antibody/VHH formats by bringing new target ideas, formats design, and targeted delivery modalities. Francois has over 24 years of experience in the Pharma industry, having worked at Pfizer, Abbott, Spirogen, MedImmune, Astrazeneca…
Our Management Team leverages their deep industry experience, data-driven insights and strategic innovation to empower our team of advocates who deliver novel healthcare solutions that help customers succeed in an increasingly challenging business climate.
